Visx CustomVue approved for hyperopia
This article was originally published in The Gray Sheet
Executive Summary
Vision correction system is the first wavefront-guided laser cleared by FDA for hyperopia with or without astigmatism, Visx says. The expanded indication increases the percentage of the 50 mil.-60 mil. people eligible for LASIK from 75% to 90%. CustomVue previously was approved for low-to-moderate myopia and astigmatism; studies are underway for expanded myopia treatment (1"The Gray Sheet" Nov. 1, 2004, p. 22)...